Contact: Lucky Tran
Columbia University Medical Center
Caption: These ar eimages of normal (above) and diseased retinas. Patients with MFRP mutations, a cause of retinitis pigmentosa, lose the function of most retinal cells, particularly at the periphery of the retina, leaving them with drastically reduced vision. Personalized gene therapy, using iPS cells, may offer a way to correct this genetic disorder.
Credit: Columbia University Medical Center
Usage Restrictions: None
Related news release: Patient-specific stem cells and personalized gene therapy